EN
HI
Summary
As of 13 Nov, 2026, Marksans Pharma stock price is ₹320. During the trading session, the stock has moved between an intraday low of ₹305.85 and an intraday high of ₹322.95. Over the last 52 weeks, Marksans Pharma has traded between ₹155.00 and ₹350.95.
The stock has recorded a trading volume of 20,88,574 shares,. Its Average Traded Price (ATP) is ₹314.87, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹320.00.
Marksans Pharma has an upper circuit limit of ₹367.85 and a lower circuit limit of ₹245.25. The total value traded stands at ₹65.76 CR, and the delivery percentage for the day is 50.03%.
The stock is currently traded with a market lot size of 1. Marksans Pharma also offers a dividend yield of 0.29%.
Marksans Pharma Share Price Chart
Marksans Pharma Share Key Metrics
Volume
20.89 L
Market Cap
14505.23 CR
LTQ@LTP
2@320.00
ATP
314.87
Var Margin
22.02 %
Circuit Range
245.25-367.85
Delivery %
50.03 %
Value
65.76 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Fundamentals
P/E Ratio
24.81
P/B Ratio
4.17
Div. Yield
0.29
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Marksans Pharma Resistance and Support
Pivot 306.68
Resistance
First Resistance
310.31
Second Resistance
314.08
Third Resistance
317.71
Support
First Support
302.91
Second Support
299.28
Third Support
295.51
Marksans Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 306 | 320 | 4.39% | 322.95 | 305.85 |
| Wed Nov 11 2026 | 310 | 306.54 | -0.72% | 310.45 | 303.04 |
| Mon Nov 09 2026 | 305.6 | 308.75 | 1.65% | 313.5 | 305.2 |
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
null
Nov 04 2026 16:56:04
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma reported record Q2 FY27 revenue of Rs.940 crores (up 30.5% YoY) and net profit of Rs.143.5 crores (up 44.8% YoY). Both US and Europe formulation businesses posted their highest-ever quarterly revenues, reflecting broad-based growth.
Nov 04 2026 13:42:41
Read More
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Natco Pharma Ltd.
808.80
-0.15 (0.02%)
CORONA Remedies Ltd.
2342.20
-25.50 (1.08%)
Jubilant Pharmova Ltd.
982.95
-4.55 (0.46%)
Molbio Diagnostics Ltd.
1394.10
75.50 (5.73%)
Vijaya Diagnostic Centre Ltd.
1415.60
-8.20 (0.58%)
Sudeep Pharma Ltd.
1205.50
-2.20 (0.18%)
Rainbow Children's Medicare Ltd.
1292.70
11.80 (0.92%)
Alivus Life Sciences Ltd.
1443.70
-11.20 (0.77%)
Concord Biotech Ltd.
601.80
4.60 (0.77%)
Metropolis Healthcare Ltd.
565.20
-10.95 (1.90%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 320 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 24.81. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.17. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 14505.23 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 350.95 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MARKSANS
